Epigenetic biomarkers are specific biological markers obtained by analyzing DNA methylation patterns in your genome.
The uniqueness of epigenetic biomarkers lies in their dynamism, as they are formed by the interaction of genes and environmental factors (nutrition, lifestyle, exposure to toxins and stress levels)
Epigenetic biomarkers provide unique insights into ongoing biological functions by predicting levels of nutrients, metabolites, and other important biochemical compounds.
Their main advantage is their ability to detect hidden imbalances and potential risks earlier than traditional laboratory biomarkers. This makes them a valuable tool in personalized medicine, nutrigenetics and preventive strategies for health maintenance.
Epigenetic biomarkers are not equal to clinical laboratory tests, but complement rather than replace them. On average, epigenetic biomarkers are superior to traditional laboratory biomarkers in both prediction and diagnosis:
- 62% of epigenetic biomarkers are more strongly associated with disease progression.
- 64% of epigenetic biomarkers are diagnostically more significant.
- Epigenetic biomarkers demonstrate 90% accuracy in detecting abnormalities from clinical norms.
Epigenetic biomarkers can predict the development of (help diagnose) 12 major chronic diseases: cardiovascular, type 2 diabetes, chronic kidney disease, cognitive impairment, and all-cause mortality.
Epigenetic biomarkers demonstrate 90% overall accuracy in detecting deviations from clinical norms; high specificity (94%) and sensitivity (76%) in clinical laboratory tests.
EBs provide a more stable and comprehensive view of your health over time, reflecting long-term impacts and trends rather than short-term fluctuations (as with lab markers).